Translational control of the myocardial inflammatory response mediates cardiac ischemia/reperfusion injury
Christoph P. Hofmann(Heidelberg University), Mirko Völkers(Heidelberg University), Fereshteh S. Younesi(St. Michael's Hospital), Ellen Malovrh(Heidelberg University), Hugo A. Katus(Heidelberg University), Florian Leuschner(Heidelberg University), Claudia Stroh(Heidelberg University), Ole M. Schwerdt(Heidelberg University), Adrian Serafin(Heidelberg University), Clara Sandmann(Heidelberg University), Ingmar S. Meyer(Heidelberg University), Florian Sicklinger(Heidelberg University), Norbert Frey(Heidelberg University), Lonny Jürgensen(Heidelberg University), Verena Kamuf‐Schenk(Heidelberg University)
Cited by 0
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k